Movicol

Macrogol 3350, the active ingredient in Movicol, is an osmotic laxative presented as an oral solution for oral use. It treats constipation in adults and children by softening stool and facilitating bowel movements. Movicol is commonly prescribed for functional constipation and for patients requiring gentle bowel cleansing.

GNH USA supplies Movicol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol is an osmotic laxative indicated for conditions affecting bowel motility and stool consistency.

- Constipation: softens stool and promotes regular bowel movements. - Chronic constipation: provides long‑term relief for persistent difficulty in evacuating. - Opioid‑induced constipation: counteracts reduced gastrointestinal motility caused by opioid therapy.

Movicol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness or swelling in the abdomen. - Nausea: mild to moderate sensation of wanting to vomit. - Flatulence: increased intestinal gas. - Diarrhoea: loose, watery stools occurring more frequently.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal levels of sodium, potassium, or chloride. - Severe dehydration: excessive loss of body fluids. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: intense or persistent pain requiring medical attention.

Before initiating Movicol therapy, consider the following safety measures.

- Renal function assessment: evaluate kidney status to avoid fluid overload. - Electrolyte monitoring: check serum electrolytes, especially in long‑term use. - Use caution in the elderly: increased susceptibility to dehydration. - Contraindication in intestinal obstruction: avoid if bowel blockage is suspected. - Store at room temperature: keep in the original pack, protect from moisture.

Movicol can interact with other medications, influencing safety or efficacy.

Major Interactions (Avoid): - Concurrent osmotic laxatives: risk of excessive fluid loss. - Loop diuretics: may exacerbate electrolyte disturbances. - Mineralocorticoids: potential for sodium and water retention imbalance.

Moderate Interactions (Monitor Closely): - NSAIDs: increased risk of renal impairment. - ACE inhibitors: monitor blood pressure and electrolytes. - Antacids containing sodium: may contribute to sodium load.